RhoB Loss Prevents Streptozotocin-Induced Diabetes and Ameliorates Diabetic Complications in Mice
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (1) , 245-252
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL071049)
- American Diabetes Association (705RA10)
This publication has 28 references indexed in Scilit:
- Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferationGenes & Development, 2009
- Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in MiceDiabetes, 2009
- Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer GrowthCancer Research, 2009
- The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductaseBiochemical and Biophysical Research Communications, 2009
- Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitorsBiochemical Pharmacology, 2008
- Epigenetic regulation of RhoB loss of expression in lung cancerBMC Cancer, 2007
- Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic MiceThe Journal of Pharmacology and Experimental Therapeutics, 2007
- RhoB affects macrophage adhesion, integrin expression and migrationExperimental Cell Research, 2007
- Effects of Simvastatin on Oxidative Stress in Streptozotocin-Induced Diabetic Rats: A Role for Glomeruli ProtectionNephron Experimental Nephrology, 2005
- Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell lineOncogene, 2003